Phibro Animal Health | PAHC - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Align Technology USD 462.67M 2.67M 2026-06
ANI Pharmaceuticals USD 91.66M 18.01M 2026-06
Aurora Cannabis CAD 41.4M 781K 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Canopy Growth CAD 31.17M 2.27M 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Eli Lilly USD 3.43B 496M 2026-06
Henry Schein USD 831M 22M 2026-06
Idexx Laboratories USD 288.09M 11.76M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Merck USD 2.89B 219M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Pacira USD 91.81M 7.93M 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 43.3M 13.02M 2026-06
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Zoetis USD 592M 4M 2026-06